US21874A1060
US21874A1060
Core Scientific, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 319.019.000 | 510.672.000 | 37.5% |
| Cost of Revenue | 281.121.000 | 389.602.000 | 27.8% |
| Gross Profit | 37.898.000 | 121.070.000 | 68.7% |
| 262.448.000 | 133.299.000 | 96.9% | |
| Operating Income | -224.550.000 | -12.229.000 | 1736.2% |
| Pretax Income | -288.033.000 | -1.437.015.000 | 80.0% |
| Net Income Common Stockholders | -288.616.000 | -1.437.874.000 | 79.9% |
| -- | -- | -- | |
| -- | -- | -- |